StemCell InstituteJP:7096
| Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2023 | Mar 31,
2024 |
|---|
| Cash and deposits | - | 2,465 | 3,025 | 2,743 | 3,511 | 3,324 | 2,846 |
|---|
| Accounts receivable - trade | - | 179 | 279 | 280 | 594 | 1,141 | 1,588 |
|---|
| Raw materials and supplies | - | 13 | 16 | 32 | 40 | 39 | 42 |
|---|
| Prepaid expenses | - | 18 | 27 | 30 | 32 | 44 | 40 |
|---|
| Other | - | 2 | 2 | 1 | 2 | 2 | 4 |
|---|
| Allowance for doubtful accounts | - | -1 | -2 | -1 | -2 | -4 | -4 |
|---|
| Current assets | - | 2,676 | 3,348 | 3,150 | 4,178 | 4,545 | 4,515 |
|---|
| Buildings | - | 96 | 100 | 503 | 583 | 617 | 635 |
|---|
| Tools, furniture and fixtures | - | 242 | 288 | 381 | 459 | 516 | 595 |
|---|
| Leased assets | - | - | - | - | - | 6 | 10 |
|---|
| Accumulated depreciation | - | -257 | -281 | -307 | -394 | -490 | -575 |
|---|
| Property, plant and equipment | - | 81 | 106 | 577 | 648 | 648 | 665 |
|---|
| Software | - | 5 | 7 | 16 | 25 | 25 | 22 |
|---|
| Software in progress | - | - | - | - | - | - | 20 |
|---|
| Intangible assets | - | 6 | 8 | 16 | 25 | 25 | 42 |
|---|
| Investment securities | - | 0 | - | 105 | 105 | 243 | 513 |
|---|
| Long-term loans receivable from directors (and other officers) | - | - | - | - | 133 | 133 | 133 |
|---|
| Shares of subsidiaries and associates | - | - | - | - | - | 0 | 0 |
|---|
| Long-term loans receivable from subsidiaries and associates | - | - | - | - | - | 5 | 5 |
|---|
| Long-term prepaid expenses | - | 1 | 1 | 1 | 2 | 1 | 7 |
|---|
| Long-term time deposits | - | - | - | - | - | - | 500 |
|---|
| Deferred tax assets | - | 13 | 22 | 20 | 28 | 44 | 5 |
|---|
| Other | - | 36 | 78 | 89 | 96 | 166 | 157 |
|---|
| Investments and other assets | - | 50 | 102 | 216 | 365 | 594 | 1,321 |
|---|
| Non-current assets | - | 138 | 217 | 808 | 1,037 | 1,266 | 2,028 |
|---|
| Assets | - | 2,813 | 3,565 | 3,958 | 5,216 | 5,812 | 6,543 |
|---|
| Accounts payable - trade | - | 17 | 17 | 21 | 30 | 30 | 35 |
|---|
| Accounts payable - other | - | 51 | 33 | 106 | 75 | 130 | 91 |
|---|
| Accrued expenses | - | 16 | 17 | 15 | 17 | 17 | 21 |
|---|
| Income taxes payable | - | 61 | 84 | - | 78 | 62 | 89 |
|---|
| Advances received | - | 1,636 | 2,059 | 2,396 | 2,745 | 3,095 | 3,420 |
|---|
| Lease liabilities | - | - | - | - | - | 1 | 2 |
|---|
| Deposits received | - | 7 | 6 | 7 | 7 | 8 | 9 |
|---|
| Provision for bonuses | - | 23 | 39 | 44 | 43 | 49 | 51 |
|---|
| Other | - | 21 | 47 | 1 | 57 | 39 | 42 |
|---|
| Current liabilities | - | 1,831 | 2,302 | 2,589 | 3,052 | 3,432 | 3,760 |
|---|
| Provision for retirement benefits for directors (and other officers) | - | - | 3 | 6 | 9 | 21 | 28 |
|---|
| Lease liabilities | - | - | - | - | - | 5 | 7 |
|---|
| Asset retirement obligations | - | - | - | 41 | 51 | 56 | 56 |
|---|
| Non-current liabilities | - | - | 3 | 47 | 60 | 81 | 90 |
|---|
| Liabilities | - | 1,831 | 2,305 | 2,636 | 3,112 | 3,513 | 3,850 |
|---|
| Share capital | - | 375 | 375 | 375 | 705 | 705 | 705 |
|---|
| Legal capital surplus | - | 260 | 260 | 260 | 590 | 590 | 590 |
|---|
| Capital surplus | - | 260 | 260 | 260 | 590 | 590 | 590 |
|---|
| Retained earnings brought forward | - | 348 | 625 | 688 | 809 | 1,007 | 1,318 |
|---|
| Retained earnings | - | 348 | 625 | 688 | 809 | 1,007 | 1,318 |
|---|
| Treasury shares | - | - | - | - | - | -0 | -0 |
|---|
| Shareholders' equity | - | 982 | 1,260 | 1,322 | 2,104 | 2,302 | 2,613 |
|---|
| Valuation difference on available-for-sale securities | - | - | - | - | - | -3 | 80 |
|---|
| Valuation and translation adjustments | - | - | - | - | - | -3 | 80 |
|---|
| Net assets | 840 | 982 | 1,260 | 1,322 | 2,104 | 2,299 | 2,693 |
|---|
| Liabilities and net assets | - | 2,813 | 3,565 | 3,958 | 5,216 | 5,812 | 6,543 |
|---|